The Epidermal Growth Factor Receptor (EGFR) operates as a critical regulatory component in cellular growth and survival mechanisms. When this receptor experiences genetic modifications or becomes hyperactivated, it promotes aggressive cancer cell multiplication and tumor development. EGFR inhibitors represent sophisticated targeted medications designed to block this receptor's functional...
English
العربية
Français
Español
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά
Tiếng Việt